微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-024575 Size: 6 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950142-20-001148 Size: 10 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-021486 Size: 15 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-021345 Size: 5 KB 网页链接
$Exagen(XGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-021339 Size: 6 KB 网页链接
$Exagen(XGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001274737-20-000026 Act: 34 Size: 11 MB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-20-000024 Act: 34 Size: 241 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-021042 Size: 11 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-021043 Size: 7 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 1.01 and 2.03 Accession Number: 0001274737-20-000016 Act: 34 Size: 41 KB 网页链接